International Business Machines Corporation IBM ← Back to all reports

International Business Machines Corporation

IBM · Technology
B ★★★ Hold
Jul 26, 2026 · Score 75 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $214.19
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $205.00 ($195.00–$215.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $246.80
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+15.2%

Type A - International Business Machines Corporation (IBM) 20260726 Stock Analysis

📅 IBM Key Upcoming Events

🏢 Step 1: IBM Company Overview & Business Model

Q1-A1. What is IBM?

Q1-A2. How Does IBM Make Money?

Q1-A3. IBM’s Revenue Segments & Core Income Sources

Q1-A4. Who Are IBM’s Competitors?

Q1-A5. IBM Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: IBM’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does IBM Have a Durable Economic Moat?

Q2-A2. Is IBM’s Growth Sustainable?

Q2-A3. How Does IBM Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is IBM Profitable? Financial Health Analysis

Q3-A2. How Profitable Is IBM? (Margins & ROIC)

Q3-A3. What Drives IBM’s Returns? (ROIC Breakdown)

Q3-A4. Are IBM’s Earnings High Quality?

Q3-A5. Is IBM’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: IBM Forensic Accounting & Dilution Review

Q4-A1. Does IBM Have Accounting Red Flags?

Q4-A2. Is IBM Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is IBM’s Cash Flow?

Q4-A4. Is IBM Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: IBM Management & Shareholder Alignment

Q5-A1. Can You Trust IBM’s Management? (Guidance Track Record)

Q5-A2. What Are IBM Insiders Doing?

Q5-A3. Is IBM’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: IBM Market Flow & Sentiment

Q6-A1. Analyst Consensus vs IBM Guidance

Q6-A2. What Is IBM’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: IBM Catalysts & Price Triggers

Q7-A1. What Could Move IBM Stock? (Top 3 Catalysts)

Q7-A2. IBM’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is IBM Fairly Valued? Valuation Analysis

Q8-A1. IBM’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. IBM vs Peers: Valuation Comparison

Q8-A3. Is IBM Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into IBM? (Reverse DCF)

Q8-A5. Valuation Cross-Check

Q8-A6. IBM’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of IBM? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to IBM?

Q9-A2. How Sensitive Is IBM to the Economy?

Q9-A3. IBM Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: IBM Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy IBM? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. IBM’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is IBM’s Disastrous 42% Plunge in Q2 Mainframe Revenue a Structural Extinction Event or a Predictable Cyclical Trough?

Q2: Can IBM’s 16x Forward P/E Be Justified by the Electrification Supercycle and Hybrid Cloud Transition?

Q3: Will the Aggressive Monetization of Confluent and HashiCorp Destroy IBM’s Developer Goodwill?

Q4: Does IBM’s Strategy to Expand Quantum Computing via HRL Laboratories Present Tangible Value?

Q5: Is the $12.5B Generative AI Book of Business Merely Unbilled Consulting Labor?

Q6: Can the $5 Billion Lightwell Initiative Successfully Monetize Open-Source Vulnerabilities?

Q7: Does the $62 Billion Debt Load Cripple IBM’s Ability to Fund Future M&A?

Q8: Will Arvind Krishna’s Credibility Recover Before the End of 2026?

Q9: Can the Confluent Acquisition Truly Deliver an “Agentic AI” Ecosystem?

Q10: Is IBM’s Turnaround Permanently Anchored by Its Low-Margin Consulting Division?

Rating History

Rating History shows the Rating assigned on each report date. We leave scores out of the timeline because reports from different periods may follow different rating scales. The score remains visible in each report that is still available.

  1. 2026-07-02 B
  2. 2026-07-26 B